-+ 0.00%
-+ 0.00%
-+ 0.00%

ANNEXON SUBMITS TANRUPRUBART MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY FOR GUILLAIN-BARRÉ SYNDROME

Reuters·01/08/2026 13:00:06

Please log in to view news